We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+13.44%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
AUM
$500M
AUM Growth
+$39.5M
Cap. Flow
-$1.25M
Cap. Flow %
-0.25%
Top 10 Hldgs %
26.84%
Holding
1,111
New
66
Increased
187
Reduced
301
Closed
121

Sector Composition

Rank Sector Weight
1 Technology 27.84%
2 Financials 15.73%
3 Industrials 12.04%
4 Real Estate 10.42%
5 Consumer Discretionary 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFUS icon
526
Littelfuse
LFUS
$11.6B
$21.4K ﹤0.01%
95
-12
-11% -$2.37K
KNG icon
527
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
$3.47B
$21.4K ﹤0.01%
436
OLED icon
528
Universal Display
OLED
$4.16B
$21.3K ﹤0.01%
138
-27
-16% -$3.78K
DFUS
529
Dimensional US Equity ETF
DFUS
$21.6B
$21.2K ﹤0.01%
317
+1
+0.3% +$62
MDB icon
530
MongoDB
MDB
$33.5B
$21.2K ﹤0.01%
101
-52
-34% -$9.61K
CNI icon
531
Canadian National Railway
CNI
$75.7B
$20.8K ﹤0.01%
200
+100
+100% +$10.2K
HLT icon
532
Hilton Worldwide
HLT
$70B
$20.8K ﹤0.01%
78
MEDP icon
533
Medpace
MEDP
$16.8B
$20.4K ﹤0.01%
65
CVE icon
534
Cenovus Energy
CVE
$54.5B
$20.4K ﹤0.01%
1,500
-200
-12% -$2.6K
AMCR icon
535
Amcor
AMCR
$21.8B
$20.2K ﹤0.01%
439
BBIO icon
536
BridgeBio Pharma
BBIO
$16.6B
$19.9K ﹤0.01%
+460
New +$16.7K
ANDE icon
537
Andersons Inc
ANDE
$2.23B
$19.7K ﹤0.01%
537
+1
+0.2% +$37
IVE icon
538
iShares S&P 500 Value ETF
IVE
$50B
$19.5K ﹤0.01%
100
CXT icon
539
Crane NXT
CXT
$2.96B
$19.5K ﹤0.01%
362
+1
+0.3% +$51
CC icon
540
Chemours
CC
$2.2B
$19.5K ﹤0.01%
1,700
-214
-11% -$2.41K
TTWO icon
541
Take-Two Interactive
TTWO
$47.4B
$19.4K ﹤0.01%
80
-31
-28% -$6.99K
IWD icon
542
iShares Russell 1000 Value ETF
IWD
$84.2B
$19.4K ﹤0.01%
100
-31
-24% -$5.74K
VTRS icon
543
Viatris
VTRS
$18.7B
$19.3K ﹤0.01%
2,164
-83
-4% -$702
CRVS icon
544
Corvus Pharmaceuticals
CRVS
$1.16B
$19.1K ﹤0.01%
+4,775
New +$17.4K
PAVE icon
545
Global X US Infrastructure Development ETF
PAVE
$14.3B
$18.7K ﹤0.01%
429
-58
-12% -$2.32K
ALNY icon
546
Alnylam Pharmaceuticals
ALNY
$29B
$18.7K ﹤0.01%
57
MET icon
547
MetLife
MET
$61.7B
$18.6K ﹤0.01%
231
COLL icon
548
Collegium Pharmaceutical
COLL
$882M
$18.6K ﹤0.01%
629
TWST icon
549
Twist Bioscience
TWST
$7.83B
$18.5K ﹤0.01%
+504
New +$17.4K
MGPI icon
550
MGP Ingredients
MGPI
$381M
$18K ﹤0.01%
602
+2
+0.3% +$59

Similar funds

Truvestments Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Truvestments Capital held 1,111 positions worth $500M, up 8.6% from $461M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Truvestments Capital's Q2 2025 filing shows 66 new, 187 increased, 301 reduced and 121 closed positions. Its largest new stake was FundStrat Granny Shots US Large Cap ETF: 16,250 shares worth $369K. The largest sale was Wells Fargo, an estimated $2.11M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.

  • Truvestments Capital's largest Q2 2025 buy was FundStrat Granny Shots US Large Cap ETF: 16,250 shares worth $369K.
  • Truvestments Capital added most to Strategy Inc in Q2 2025, an estimated $1.88M increase.
  • Truvestments Capital's biggest Q2 2025 reduction was Wells Fargo, cutting an estimated $2.11M.
  • Truvestments Capital fully exited Patterson Companies, Inc. in Q2 2025, selling an estimated $141K.
  • Truvestments Capital's ten largest holdings make up 27% of its $500M portfolio in Q2 2025.
  • Truvestments Capital opened 66 new positions and closed 121 in Q2 2025.
  • Truvestments Capital's portfolio value rose 8.6% quarter-over-quarter to $500M.

Based on Truvestments Capital's 13F filing for Q2 2025, filed 13 Aug 2025.